Direct Thrombin Inhibitor Dabigatran Compromises Pulmonary Endothelial Integrity in a Murine Model of Breast Cancer Metastasis to the Lungs; the Role of Platelets and Inflammation-Associated Haemostasis.

Saved in:
Bibliographic Details
Title: Direct Thrombin Inhibitor Dabigatran Compromises Pulmonary Endothelial Integrity in a Murine Model of Breast Cancer Metastasis to the Lungs; the Role of Platelets and Inflammation-Associated Haemostasis.
Authors: Smeda M; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland., Stojak M; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland., Przyborowski K; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland., Sternak M; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland., Suraj-Prazmowska J; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland., Kus K; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland., Derszniak K; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.; Faculty of Chemistry, Jagiellonian University, Krakow, Poland., Jasztal A; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland., Kij A; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland., Kurpinska A; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland., Kieronska-Rudek A; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.; Department of Pharmacology, Jagiellonian University Medical College, Krakow, Poland., Wojnar-Lason K; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.; Department of Pharmacology, Jagiellonian University Medical College, Krakow, Poland., Buczek E; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland., Mohaissen T; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.; Faculty of Pharmacy, Jagiellonian University Medical College, Krakow, Poland., Chlopicki S; Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.; Department of Pharmacology, Jagiellonian University Medical College, Krakow, Poland.
Source: Frontiers in pharmacology [Front Pharmacol] 2022 Feb 28; Vol. 13, pp. 834472. Date of Electronic Publication: 2022 Feb 28 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first